These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25951940)

  • 1. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium.
    Klingensmith GJ; Connor CG; Ruedy KJ; Beck RW; Kollman C; Haro H; Wood JR; Lee JM; Willi SM; Cengiz E; Tamborlane WV;
    Pediatr Diabetes; 2016 Jun; 17(4):266-73. PubMed ID: 25951940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry.
    Gregg B; Connor CG; Cheng P; Ruedy KJ; Beck RW; Kollman C; Schatz D; Cengiz E; Tamborlane WV; Klingensmith GJ; Lee JM;
    Pediatr Diabetes; 2016 Jun; 17(4):274-80. PubMed ID: 25940861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.
    Nambam B; Silverstein J; Cheng P; Ruedy KJ; Beck RW; Paul Wadwa R; Klingensmith G; Willi SM; Wood JR; Bacha F; Thomas IH; Tamborlane WV;
    Pediatr Diabetes; 2017 May; 18(3):222-229. PubMed ID: 26970319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study.
    Wolf RM; Cheng P; Gal RL; Beaulieu LC; Kollman C; Isganaitis E; Magge S; Mastrandrea LD; Klingensmith GJ; Tamborlane W; Van Name M;
    Pediatr Diabetes; 2022 Jun; 23(4):439-446. PubMed ID: 35138021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries.
    Klingensmith GJ; Lanzinger S; Tamborlane WV; Hofer SE; Cheng P; de Beaufort C; Gal RL; Reinehr T; Kollman C; Holl RW
    Pediatr Diabetes; 2018 Nov; 19(7):1156-1163. PubMed ID: 29923263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
    Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
    Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study.
    Kelsey MM; Geffner ME; Guandalini C; Pyle L; Tamborlane WV; Zeitler PS; White NH;
    Pediatr Diabetes; 2016 May; 17(3):212-21. PubMed ID: 25690268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry.
    Bacha F; Cheng P; Gal RL; Kollman C; Tamborlane WV; Klingensmith GJ; Manseau K; Wood J; Beck RW;
    Horm Res Paediatr; 2018; 89(1):47-55. PubMed ID: 29131017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The present and future treatment of pediatric type 2 diabetes.
    Van Name MA; Guandalini C; Steffen A; Patel A; Tamborlane W
    Expert Rev Endocrinol Metab; 2018 Jul; 13(4):207-212. PubMed ID: 30063424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic ketoacidosis at diagnosis among youth with type 1 and type 2 diabetes: Results from SEARCH (United States) and YDR (India) registries.
    Praveen PA; Hockett CW; Ong TC; Amutha A; Isom SP; Jensen ET; Mohan V; Dabelea DA; D'Agostino RB; Hamman RF; Mayer-Davis EJ; Lawrence JM; Dolan LM; Kahn MG; Madhu SV; Tandon N
    Pediatr Diabetes; 2021 Feb; 22(1):40-46. PubMed ID: 31943641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross-sectional study.
    Hatun S; Yesiltepe Mutlu G; Cinaz P; Turan S; Ekberzade A; Bereket A; Erbas MY; Akcay T; Onal H; Bolu S; Arslanoglu I; Doger E; Yilmaz AA; Ucakturk A; Karabulut GS; Tuhan HÜ; Demir K; Erdeve SS; Aycan Z; Nalbantoğlu Ö; Kara C; Gungor N;
    Diabet Med; 2019 Oct; 36(10):1243-1250. PubMed ID: 31099079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study.
    Silverstein J; Cheng P; Ruedy KJ; Kollman C; Beck RW; Klingensmith GJ; Wood JR; Willi S; Bacha F; Lee J; Cengiz E; Redondo MJ; Tamborlane WV;
    Diabetes Care; 2015 Dec; 38(12):2341-3. PubMed ID: 26459274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.
    Copeland KC; Zeitler P; Geffner M; Guandalini C; Higgins J; Hirst K; Kaufman FR; Linder B; Marcovina S; McGuigan P; Pyle L; Tamborlane W; Willi S;
    J Clin Endocrinol Metab; 2011 Jan; 96(1):159-67. PubMed ID: 20962021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which obese youth are at increased risk for type 2 diabetes? Latent class analysis and comparison with diabetic youth.
    Greig F; Hyman S; Wallach E; Hildebrandt T; Rapaport R
    Pediatr Diabetes; 2012 Mar; 13(2):181-8. PubMed ID: 22050535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Hyperosmolar Hyperglycemic State in Pediatric Type 2 Diabetes.
    Everett EM; Copeland T; Wisk LE; Chao LC
    Pediatr Diabetes; 2023; 2023():. PubMed ID: 37614411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control.
    Van Name MA; Cheng P; Gal RL; Kollman C; Lynch J; Nelson B; Tamborlane WV;
    Diabet Med; 2020 May; 37(5):863-867. PubMed ID: 31943374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes.
    Farrell R; Bethin K; Klingensmith G; Tamborlane WV; Gubitosi-Klug R
    Pediatr Diabetes; 2017 Nov; 18(7):574-578. PubMed ID: 27807915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycaemic hyperosmolar state in an obese prepubertal girl with type 2 diabetes: case report and critical approach to diagnosis and therapy.
    Mohn A; Polidori N; Castorani V; Comegna L; Giannini C; Chiarelli F; Blasetti A
    Ital J Pediatr; 2021 Feb; 47(1):38. PubMed ID: 33602256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment regimens and glycosylated hemoglobin levels in youth with Type 1 and Type 2 diabetes: Data from SEARCH (United States) and YDR (India) registries.
    Amutha A; Praveen PA; Hockett CW; Ong TC; Jensen ET; Isom SP; D'Agostino RBJ; Hamman RF; Mayer-Davis EJ; Wadwa RP; Lawrence JM; Pihoker C; Kahn MG; Dabelea D; Tandon N; Mohan V
    Pediatr Diabetes; 2021 Feb; 22(1):31-39. PubMed ID: 32134536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin in obese children and adolescents: the MOCA trial.
    Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.